Drugs / Artelac® Complete MDO® Eye Drops
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07593885 | Apr → Nov 2026 expected | dry eye syndrome | Dr. Gerhard Mann chem.-pharm. Fabrik GmbH | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Artelac Complete MDO Eye Drops | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07593885 ↗ |
| Route | Other | “Self-administered eye drops” NCT07593885 ↗ |